BridgeBio Oncology Therapeutics
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -186 | -194 | ||
EBITDA | -56,454 | -45,993 | -43,214 | -49,000 |
EBIT | -46,179 | -43,408 | -49,181 | |
Net Income | -56,454 | -42,106 | -38,797 | -44,757 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -44,408 | -35,941 | -42,307 | -71,159 |
Cash | 54,063 | 52,658 | 373,687 | 408,741 |
Basic Shares | 80 | 80 | 79,987 | 43,491 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -610 | ||
EBITDA | -145,209 | -80,655 | -64,679 |
EBIT | -145,819 | -80,863 | -64,771 |
Net Income | -134,044 | -74,275 | -64,699 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -114,500 | -763 | -52,493 |
Cash | 373,687 | 1,697 | 250 |
Basic Shares | 31,144 | 12 | 20,485 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.71 |
2026-03-31 | -$526.11 |
2025-12-31 | -$0.49 |
2025-09-30 | -$1.03 |